13,000.00

Content Details
Information on this page was last modified on : 2023/08/16 7:09:18 PM

Humatrope 36 iu 12mg (somatropin) imp ^

(3 customer reviews)
Belongs to Category

Alternate brands of Humatrope 36 iu 12mg (somatropin) imp ^

Brand Name Price Savings
Humatrope 18 iu 6mg (somatropin) ^  13,000.00 You can save 0
Norditropin NordiLet Flexpen Injection 5 mg Pre filled Penx1.5 mL  14,000.00 You will pay -1000 more
Norditropin Injection 4 IU 1 Vialx1.3 mL  14,000.00 You will pay -1000 more
Humatrope Injection 15 IU 1 Vial  6,250.00 You can save 6750
Eutropin Injection 4 IU 1 Vial  1,500.00 You can save 11500
List of alternate brands

Humatrope 36 iu 12mg (somatropin) is now available in Pakistan. Price of Humatrope 36 IU is Rs. 13,000 in Pakistan as of 16th August 2023

How it works

This medicine works by stimulating the growth of bones and muscles. It also helps fat and muscle tissues to develop in adequate amounts.

Side effects

Major & minor side effects for Humatrope 36 iu 12mg (somatropin) imp ^

  • Bone and joint pain
  • Puffy fingers
  • Swollen joints
  • Injection site bruising and red coloration
  • Burning, numbness, tingling in the arms and feet
  • Muscle cramps and stiffness
  • Severe headache severe
  • Visual disturbances severe
  • Nausea and Vomiting
  • Blood in urine and stools severe
  • Flu like symptoms severe
  • Confusion
  • Constipation
  • Difficult or painful urination
  • Dry mouth
  • Fast/irregular heart beat severe
  • Loss of appetite
  • Shivering severe
  • Yellowing of skin and eyes severe
  • White patches in the mouth or on the tongue
  • Mild to moderate depression severe
  • Hair loss or thinning of the hair rare
  • Diarrhea
  • Dizziness

Uses of Humatrope 36 iu 12mg (somatropin) imp ^

What is it prescribed for?

  • Human growth hormone deficiency

    This medicine is used for the treatment of growth failure due to inadequate secretion of the growth hormone. It is used to treat growth hormone deficiency in both children and adults. The lack of growth hormone in adults may or may not be coupled with multiple hormone deficiencies.

  • Cachexia

    This medicine is used to treat extreme weight loss and muscle wasting in adults and children caused due to severe chronic illnesses such as AIDS and certain forms of cancer.

  • Short bowel syndrome

    This medicine is used along with dietary adjustments and nutritional supplementation to treat short bowel syndrome in adults. Short bowel syndrome is a malabsorption disorder caused by a lack of functional small intestine, causing severe diarrhea, malnutrition, and weight loss.

  • Turner's syndrome

    This medicine is used to treat growth failure in girls associated with a congenital defect called Turner's syndrome.

  • Idiopathic short stature

    This medicine is used to treat short stature in children, which is not attributed to the lack of growth hormone secretion.Growth retardation due to chronic renal failure

  • Growth retardation due to chronic renal failure

    This medicine is used to treat growth deficiencies in children caused due to long-term kidney function impairment.

  • Noonan's syndrome

    This medicine is used to treat growth deficiency in children, which is associated with a genetic disorder called Noonan Syndrome.

  • Short stature for age

    This medicine is used to treat short stature of children whose epiphyses are not closed and for whom diagnostic evaluation excludes other causes associated with short stature.

Concerns

Frequently asked questions

  • Onset of action

    The amount of time taken by this medicine to show its effect is not clinically established.

  • Duration of Effect

    The amount of time for which this medicine remains effective is not clinically established.

  • Safe with Alchohol?

    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

  • Is it habit forming?

    No habit-forming tendencies were reported.

  • Usage in pregnancy?

    This medicine is not recommended for use in pregnant women unless absolutely necessary. Your doctor will determine the best course of treatment after evaluating the potential benefits and risks associated with the use of this medicine.

  • Usage while breast-feeding?

    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. Your doctor will determine the best course of treatment after evaluating the potential benefits and risks associated with the use of this medicine.

When not to use?

  • Acute critical illness

    This medicine is not recommended for use in patients with acute critical illness followed by open heart surgery, abdominal surgery, acute respiratory failure, or multiple accidental trauma due to the increased risk of mortality.

  • Prader-Willi Syndrome with associated complications

    This medicine is not recommended for use in patients with Prader-Willi Syndrome who are severely obese or have a severe respiratory disease due to the increased risk of mortality.

  • Active malignancy

    This medicine is not recommended for use in patients with an active malignancy due to the increased risk of worsening of the patient’s condition. Any preexisting malignancy should be inactive and its treatment course should be completed for therapy with this medicine to begin.

  • Diabetic retinopathy

    This medicine is not recommended for use in patients with active proliferative or severe non-proliferative diabetic retinopathy due to the increased risk of worsening of the patient’s condition.

  • Closed epiphyses

    This medicine is not recommended for growth promotion in children with closed epiphyses.

  • Allergy

    This medicine is not recommended for use in patients with a known allergy to Humatrope 36 iu 12mg (somatropin) imp ^ , benzyl alcohol, or any other inactive ingredients present in the formulation.

Warnings

Warnings for special population
  • Pregnancy

    This medicine is not recommended for use in pregnant women unless absolutely necessary. Your doctor will determine the best course of treatment after evaluating the potential benefits and risks associated with the use of this medicine.

  • Breast-feeding

    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. Your doctor will determine the best course of treatment after evaluating the potential benefits and risks associated with the use of this medicine.

General Warnings
  • Other medicines

    Eutropin Injection may interact with many other medicines and may cause severe adverse effects. Hence, it is advised that you inform the doctor about all your current medicines including any herbs and supplements before beginning treatment with this medicine.

  • Severe illness

    This medicine should be administered with caution in patients with an acute and severe illness. Use of this medicine should be discontinued if the symptoms of the illness worsen.

  • Relapse of cancer

    This medicine should be used with extreme caution in patients, especially children, who have undergone treatment for cancer. Use of this medicine may cause a relapse and hence regular clinical monitoring is advised.

  • Diabetes Mellitus

    This medicine should be used with caution in patients with diabetes due to the increased risk of worsening of the patient’s condition. Appropriate corrective measures, dose adjustments, and monitoring of blood glucose levels may be necessary while receiving this medicine. An alternative treatment option may be required in some cases based on the clinical condition.

  • Intracranial hypertension

    Use of this medicine may cause increased pressure around the brain, causing visual disturbances, severe headaches, nausea, and vomiting. Contact your doctor immediately if you experience these symptoms regularly after receiving this medicine.

  • Fluid retention

    Use of this medicine may cause fluid retention in adults. Patients may experience muscle and joint pain, tiredness, etc. for transient periods while receiving this medicine. Contact your doctor if these symptoms are persistent.

  • Hypoadrenalism

    Use of this medicine may cause a reduction in adrenal gland secretions and hence, it should be used with caution in patients with a pre-existing condition of hypoadrenalism. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

  • Thyroid hormone levels

    Reduced levels of thyroid hormone levels may make Humatrope 36 iu 12mg (somatropin) imp ^ less effective. Hence, it is advised to regularly monitor the thyroid hormone levels of patients during treatment with this medicine.

  • Pancreatitis

    Use of this medicine may rarely cause swelling of the pancreas, resulting in severe and persistent abdominal pain. Contact your doctor immediately if you experience severe abdominal pain after receiving this medicine.

Dosage

  • Missed Dose

    Administer the missed dose as soon as you remember. If it is almost time for your next dose, skip the missed dose. Do not double your dose to make up for the missed one.

  • Overdose

    Seek emergency medical treatment or contact the doctor in case of an overdose.

Interactions

Interaction with Medicines
  • Deflazacort moderate
  • Dexamethasone moderate
  • Quetiapine moderate
  • Insulin moderate
  • Armodafinil moderate
  • Bexarotene severe
  • Dapagliflozin moderate
  • Budesonide moderate
  • Carbamazepine moderate
  • Acarbose moderate
  • Diltiazem moderate
  • Hydrocortisone moderate
  • Montelukast moderate
  • Triamcinolone moderate
  • Metformin moderate
Disease interactions
  • moderate

    This medicine should be used with caution in patients with diabetes due to the increased risk of worsening of the patient’s condition. Regular monitoring of blood glucose levels is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

  • moderate

    This medicine should be used with caution in patients with hypothyroidism due to the increased risk of worsening of the patient’s condition. Regular monitoring of the thyroid function tests is necessary while receiving this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

General Instructions

Administer this medicine exactly as prescribed by the doctor. It is advised to administer this medicine in the presence of a doctor or a trained healthcare professional until you are aware of the exact procedure. Contact your doctor immediately if you experience any adverse effects. Ensure that the course of treatment is completed. Do not stop the use of this medicine without consulting your doctor.

Other details

  • Usage does not depend on food timings
  • To be taken as instructed by doctor
  • May cause sleepiness

References

Additional Information:

One of the following licensed pharmacy from the nearest location will deliver Humatrope 36 iu 12mg (somatropin) imp ^. The details of the licensed pharmacy shall be shared once you request the drugs and the respective pharmacy accepts your request based on valid prescription and availability.

Want to share this information?
Facebook
Twitter
LinkedIn
Something doesn't feel right ?

Questions and Answers

There are no questions yet. Be the first to ask a question about this product.

Only registered users are eligible to enter questions

3 reviews for Humatrope 36 iu 12mg (somatropin) imp ^

  1. junaid saleem

    junaid saleem submitted 5 stars.

  2. mirzasahib

    mirzasahib submitted 5 stars.

  3. arshad (verified owner)

    plz inform me my order is confirmed…?

Add a review
Shopping Cart